CGNH — CardioGenics Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.38m
Annual income statement for CardioGenics Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
C2011 October 31st | 2012 October 31st | 2013 October 31st | 2014 October 31st | 2015 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.009 | 0.001 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.66 | 1.32 | 2.53 | 0.974 | 0.772 |
Operating Profit | -5.65 | -1.31 | -2.53 | -0.974 | -0.772 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.76 | -1.32 | -2.94 | -2.68 | -1.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.76 | -1.32 | -2.94 | -2.68 | -1.92 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.72 | -1.31 | -2.92 | -2.68 | -1.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.72 | -1.31 | -2.92 | -2.68 | -1.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.072 | -0.023 | -0.048 | -0.043 | -0.02 |
Dividends per Share |